Tolmar Providing Refunds for Five Years of 340B Overcharges
Drug manufacturer Tolmar recently said it plans refunds to 340B covered entities for overcharges on seven generic dermatologic products purchased [...]
*Sign up for news summaries and alerts from 340B Report